A recent medical advancement in combating pancreatic cancer offers hopeful outcomes. This comes after years of dedicated research. The focus is on an experimental drug administered daily. This medication aims to extend patients’ lifespans by decelerating the disease’s progression.
Dr. Rachna Shroff plays a pivotal role in this development. As the Associate Director of Clinical Investigations at the University of Arizona Comprehensive Cancer Center, she provides crucial insights into the study’s findings and implications.
Stephanie Sy provides a platform for this discussion. Her role as a correspondent for PBS News Hour allows her to bring such stories to a wider audience. Over her career, Sy has held various positions, including roles at ABC News, Al Jazeera America, and CNN International. Her experience includes anchoring significant events, like the 2018 Midterm Elections, for Yahoo News.
Ebola Outbreak in Africa: A Serious Concern 
Gold and the Ebola Outbreak in Congo’s Mining Towns 
House Passes Bill for Veterans’ Benefit Increase 
Gene Editing in Human Embryos at Columbia University 
Melinda French Gates Commits $215 Million for Global Women’s Health 
Impact of Reduced Public Health Authority Post-COVID-19